Literature DB >> 12649522

Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations.

Tomoki Hashimoto1, Gen Wen, Michael T Lawton, Nancy J Boudreau, Andrew W Bollen, Guo-Yuan Yang, Nicholas M Barbaro, Randall T Higashida, Christopher F Dowd, Van V Halbach, William L Young.   

Abstract

BACKGROUND AND
PURPOSE: Excessive degradation of the vascular matrix by matrix metalloproteinases (MMPs) can lead to structural instability of vessels. In this study we examined the expression of MMPs and tissue inhibitors of metalloproteinases (TIMPs) in brain arteriovenous malformations (BAVMs).
METHODS: We performed gelatin zymography for MMPs and Western blot for MMP-9, MMP-2, TIMP-1, TIMP-2, TIMP-3, and TIMP-4. MMP-9 expression was localized by immunohistochemistry.
RESULTS: We analyzed 37 BAVM specimens and 9 control brain specimens from epilepsy surgery. Thirty-two BAVM patients had embolization treatment before resection. Eighteen BAVM patients had a history of hemorrhage from BAVMs. Neither MMP-2 nor TIMP-2 was detected in BAVMs or control brain specimens. Compared with control brain samples, BAVM samples had higher levels of total MMP-9, active MMP-9, pro-MMP-9, TIMP-1, and TIMP-3. TIMP-4 levels were higher in the control brain than in BAVM specimens. MMP-9 was localized to the endothelial cell/peri-endothelial cell layer and infiltrating neutrophils of BAVMs. BAVMs with venous stenosis >or=50% had higher expression of MMP-9 than BAVMs with venous stenosis <50%. There was no apparent association between total MMP-9, pro-MMP-9, or active MMP-9 levels and (1) feeding artery pressure, (2) pattern of draining vein (exclusively deep venous drainage versus any superficial drainage), and (3) BAVM size.
CONCLUSIONS: We found increased levels of MMP-9 and TIMPs in BAVMs. Abnormal balance of MMP-9 and TIMPs may contribute to vascular instability of BAVMs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12649522     DOI: 10.1161/01.STR.0000061888.71524.DF

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  47 in total

1.  Apolipoprotein E epsilon 2 is associated with new hemorrhage risk in brain arteriovenous malformations.

Authors:  Ludmila Pawlikowska; K Y Trudy Poon; Achal S Achrol; Charles E McCulloch; Connie Ha; Kristen Lum; Jonathan G Zaroff; Nerissa U Ko; S Claiborne Johnston; Stephen Sidney; Douglas A Marchuk; Michael T Lawton; Pui-Yan Kwok; William L Young
Journal:  Neurosurgery       Date:  2006-05       Impact factor: 4.654

2.  Possible pathophysiological role of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) in metastatic brain tumor-associated intracerebral hemorrhage.

Authors:  Shin Jung; Kyung-Sub Moon; Tae-Young Jung; In-Young Kim; Young-Hwa Lee; Hyang-Hwa Rhu; Heung-Suk Sun; Young-Il Jeong; Kyung-Keun Kim; Sam-Suk Kang
Journal:  J Neurooncol       Date:  2006-02       Impact factor: 4.130

Review 3.  Intracranial aneurysms: links among inflammation, hemodynamics and vascular remodeling.

Authors:  Tomoki Hashimoto; Hui Meng; William L Young
Journal:  Neurol Res       Date:  2006-06       Impact factor: 2.448

4.  Immunohistochemical analysis of TIMP-2 and collagen types I and IV in experimental spinal cord ischemia-reperfusion injury in rats.

Authors:  Ihsan Anik; Sibel Kokturk; Hamza Genc; Burak Cabuk; Kenan Koc; Sadan Yavuz; Sureyya Ceylan; Savas Ceylan; Levent Kamaci; Yonca Anik
Journal:  J Spinal Cord Med       Date:  2011       Impact factor: 1.985

Review 5.  Matrix metalloproteases: underutilized targets for drug delivery.

Authors:  Deepali G Vartak; Richard A Gemeinhart
Journal:  J Drug Target       Date:  2007-01       Impact factor: 5.121

6.  Increased expression of ephrin A1 in brain arteriovenous malformation: DNA microarray analysis.

Authors:  Atsushi Sasahara; Hidetoshi Kasuya; Hiroyuki Akagawa; Hiroshi Ujiie; Osami Kubo; Toshiyuki Sasaki; Hideaki Onda; Yoshiko Sakamoto; Boris Krischek; Tomokatsu Hori; Ituro Inoue
Journal:  Neurosurg Rev       Date:  2007-06-19       Impact factor: 3.042

7.  Brain arteriovenous malformation pathogenesis: a response-to-injury paradigm.

Authors:  Helen Kim; Hua Su; Shantel Weinsheimer; Ludmila Pawlikowska; William L Young
Journal:  Acta Neurochir Suppl       Date:  2011

8.  Notch2 regulates matrix metallopeptidase 9 via PI3K/AKT signaling in human gastric carcinoma cell MKN-45.

Authors:  Ling-Yun Guo; Yu-Min Li; Liang Qiao; Tao Liu; Yuan-Yuan Du; Jun-Qiang Zhang; Wen-Ting He; Yong-Xun Zhao; Dong-Qiang He
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

9.  Association of tumor necrosis factor-alpha-238G>A and apolipoprotein E2 polymorphisms with intracranial hemorrhage after brain arteriovenous malformation treatment.

Authors:  Achal S Achrol; Helen Kim; Ludmila Pawlikowska; K Y Trudy Poon; Charles E McCulloch; Nerissa U Ko; S Claiborne Johnston; Michael W McDermott; Jonathan G Zaroff; Michael T Lawton; Pui-Yan Kwok; William L Young
Journal:  Neurosurgery       Date:  2007-10       Impact factor: 4.654

10.  Evidence of inflammatory cell involvement in brain arteriovenous malformations.

Authors:  Yongmei Chen; Wei Zhu; Andrew W Bollen; Michael T Lawton; Nicholas M Barbaro; Christopher F Dowd; Tomoki Hashimoto; Guo-Yuan Yang; William L Young
Journal:  Neurosurgery       Date:  2008-06       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.